Y-mAbs Therapeutics YMAB reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Y-mAbs Therapeutics missed estimated earnings by 21.43%, reporting an EPS of $-0.85 versus an estimate of $-0.7.
Revenue was up $11.15 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.06 which was followed by a 6.32% drop in the share price the next day.
Here's a look at Y-mAbs Therapeutics's past performance:
Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
---|---|---|---|---|
EPS Estimate | -0.60 | -0.64 | 0.19 | -0.51 |
EPS Actual | -0.66 | -0.53 | 0.75 | -0.48 |
Revenue Estimate | 10.87M | 7.85M | 44.47M | 15.54M |
Revenue Actual | 8.96M | 10.95M | 5.38M | 20.75M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.